Trial no.:
|
PACTR202401546543440 |
Date of Approval:
|
04/01/2024 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
A randomized control study to assess the efficacy of sphenopalatine ganglion block in patients with postdural puncture headache |
Official scientific title |
A randomized control study to assess the efficacy of sphenopalatine ganglion block in patients with postdural puncture headache |
Brief summary describing the background
and objectives of the trial
|
Current treatment of postural puncture headache includes epidural blood patch (EBP), which is invasive and may result in rare but severe complications. Sphenopalatine ganglion block is suggested as a simple, minimally invasive treatment for postural puncture headache. We aimed to investigate the analgesic effect of a transmural sphenopalatine ganglion block .nnd the aim of this study is to detect the effective of sphenopalatine block in treatment of postural puncture headheb |
Type of trial |
CCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Anaesthesia |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Diagnosis / Prognosis |
Anticipated trial start date |
05/09/2023 |
Actual trial start date |
20/09/2023 |
Anticipated date of last follow up |
10/01/2024 |
Actual Last follow-up date |
30/01/2024 |
Anticipated target sample size (number of participants) |
60 |
Actual target sample size (number of participants) |
40 |
Recruitment status |
Active, not recruiting |
Publication URL |
jssub@ekb.eg |
|